Abstract
As determined with isoelectric focusing, human apo E can be saparated into three major isoforms, i.e. E2, E3 and E4 and a number of minor glycosylated isoforms (1,2). The heterogeneity of apo E is proposed to be the result of different apo E alleles, at one single genetic locus (1,2,3). At present a number of apo E variants have been described (for reference see 4). Most of these variants are the underlying metabolic defect in familial type III HLP due to a more or less pronounced defect of these variants in binding to the hepatic lipoprotein receptors (5,6). It is reported that the potential receptor binding region of the apo E molecule lies between residues 126 and 218 (7,8). Most of the type III HLP patients exhibit the apo E2 (Arg158→Cys) or E2 (Arg145→Cys) variant. Recently, we described a type III HLP patient (C.V.) with apolipoprotein phenotype E3/3 as evaluated by isoelectric focusing (9). We reported that apo E3 from patient C.V. was defective in binding to the LDL receptor on cultured fibroblasts at 4°C, as compared with apo E3 isolated from a type IV HLP patient. In this paper we describe the partial characterization and the mode of inheritance of this defective apo E3, denoted apo E3-Leiden.
Keywords
- Cysteine Residue
- Human Apolipoprotein
- Density Gradient Ultracentrifugation
- Familial Type
- Single Genetic Locus
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
G. Utermann, M. Hees and A. Steinmetz, Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinemia in man, Nature, 269:604 (1977)..
V.T. Zannis, and J.L. Breslow, Human very low density lipoprotein apoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification, Biochemistry, 20:1033 (1981).
V.T. Zannis, J.L. Breslow, G. Utermann, R.W. Mahley, K.H. Weisgraber, R.J. Havel, J.L. Goldstein, M.S. Brown, G. Schonfeld, W.R. Hazzard, and C. Blum, Proposed nomenclature of apo E isoproteins apo E genotypes and phenotypes, J. Lipid Res., 23:911 (1982).
T.L. Innerarity, K.H. Weisgraber, K.S. Arnold, S.C. Rall, and R.W. Mahley, Normalization of receptor binding of apolipoprotein E. Evidence for modulation of the binding site conformation, J. Biol. Chem., 259:7261 (1984).
S.C. Rall, K.H. Weisgraber, T.L. Innerarity, and R.W. Mahley, Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects, Proc. Natl. Acad. Sci., USA, 79:4696 (1982).
W.J. Schneider, P.T. Kovanen, M.S. Brown, J.L. Goldstein, G. Utermann, W. Weber, R.J. Havel, L. Kotite, and J.P. Kane, Familial dysbetalipoproteinemia: Abnormal binding of mutant apolipoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits and cows, J. Clin. Invest., 68:1075 (1981).
T.L. Innerarity, E.J. Friedlander, S.C. Rall, K.H. Weisgraber, and R.W. Mahley, The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments, J. Biol. Chem., 285:12341 (1983).
K.H. Weisgraber, T.L. Innerarity, K.J. Harder, R.W. Mahley, R.W. Milne, Y.L. Marcel, and J.T. Sparrow, The receptor binding domain of human apolipoprotein E. Monoclonal antibody inhibition of binding, J. Biol. Chem. 258:12348 (1983).
L.M. Havekes, J. A. Gevers Leuven, E. Van Corven, E. De Wit, and J.J. Emeis, Serum lipids, lipoproteins and apolipoprotein E phenotypes in relatives of patients with type III hyperlipoproteinemia, Eur. J. Clin. Invest., 14:7 (1984).
G. Utermann, K.H. Weisgraber, W. Weber, and R.W. Mahley, Genetic polymorphism of apolipoprotein E: a variant form of apolipoprotein distinguished by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, J. Lipid Res., 25:378 (1984).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer Science+Business Media New York
About this chapter
Cite this chapter
Havekes, L., Klasen, E., Utermann, G. (1986). Apoprotein E3-Leiden: A Variant of Human Apolipoprotein E3 Associated with Familial Type III Hyperlipoproteinemia. In: Sirtori, C.R., Nichols, A.V., Franceschini, G. (eds) Human Apolipoprotein Mutants. NATO ASI Series, vol 112. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9474-1_26
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9474-1_26
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-9476-5
Online ISBN: 978-1-4615-9474-1
eBook Packages: Springer Book Archive